Literature DB >> 20801407

Advances and challenges in translating stem cell therapies for clinical diseases.

Michael A Matthay1.   

Abstract

Mesh:

Year:  2010        PMID: 20801407     DOI: 10.1016/j.trsl.2010.07.007

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


× No keyword cloud information.
  5 in total

1.  Role of academic medical centers in cell-based therapeutic clinical trials.

Authors:  David H Rowitch; Bernard Lo
Journal:  Transl Res       Date:  2011-01-25       Impact factor: 7.012

2.  Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Authors:  Anna Krasnodembskaya; Gianluca Samarani; Yuanlin Song; Hanjing Zhuo; Xiao Su; Jae-Woo Lee; Naveen Gupta; Mario Petrini; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

3.  Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury.

Authors:  Liliya M Yamaleyeva; Nadia K Guimaraes-Souza; Louis S Krane; Sigrid Agcaoili; Kenneth Gyabaah; Anthony Atala; Tamer Aboushwareb; James J Yoo
Journal:  Stem Cells Transl Med       Date:  2012-05-03       Impact factor: 6.940

4.  Enteric bacteria and cancer stem cells.

Authors:  Jun Sun
Journal:  Cancers (Basel)       Date:  2010       Impact factor: 6.639

Review 5.  Mesenchymal stem cells in tissue repair.

Authors:  Amy M Dimarino; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Immunol       Date:  2013-09-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.